Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Columbia University Medical Center, New York

Staten Island Urological Research, Staten Island

Biomedical Research Alliance of New York (BRANY), The Bronx

University of Virginia Health System, Charlottesville

Peachtree Hematology and Oncology, Atlanta

University of Miami School of Medicine, Miami

Cleveland Clinic Foundation, Cleveland

Marshfield Clinic Foundation, Marshfield

Park Nicollet Institute, Saint Louis Park

Oncology Hematology Associates of Central Illinois,PC, Peoria

Ochsner Cancer Institute, New Orleans

Comprehensive Cancer Centers of Nevada, Las Vegas

UCLA Clinical Research Unit, Los Angeles

Cancer Care Associates Medical Group, Inc, Redondo Beach

North Valley Hematology/Oncology Medical Group, The Thomas and Dorothy Leavey Cancer Center, Northridge

Providence Saint Joseph's Medical Center (PSJMC), Burbank

Central Hematology Oncology Medical Group Inc, Alhambra

Pacific Oncology & Hematology Associates, Encinitas

Virginia K. Crosson Cancer Center, Fullerton

Ventura County Hematology-Oncology Specialists, Oxnard

Sansum Santa Barbara Medical Foundation Clinic, Santa Barbara

Santa Barbara Hematology Oncology Medical Group, Inc., Santa Barbara

Comprehensive Blood and Cancer Center, Bakersfield

Central Coast Medical Oncology Corporation, Santa Maria

Stanford University Medical Center-Cancer Center, Stanford

Pacific Shores Medical Group, Long Beach

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore